Green Cures & Botanical Distribution, Inc. has announced that it will introduce its first CDB derived product to the public during the month of June 2014. Green Cures’ set of 30 CBD Capsules will initially contain 50 milligrams of Pure CBD-Hemp Oil per capsule.

Green Cures’ CBD Capsules have a low THC content that falls within federal guidelines; therefore, Green Cures will be able to market, distribute and sell its upcoming product online and through retailers across the nation.  According to published scientific and clinical studies, CBD may act in the form of an experimental model to improve a wide range of conditions, including epilepsy, arthritis, rheumatoid, diabetes, alcoholism, chronic pain, schizophrenia, antibiotic-resistant infections, and other neurological disorders.

Additionally, Management of Green Cures announced that it is also exploring additional opportunities to expand its services and operations within the hemp and cannabis industry, particularly, in the field of agriculture.

“Currently, in the United States, the demand for high quality raw material throughout the hemp industry and cannabis medicinal field outstrips the supply; therefore, we are exploring the possibility of being able to supply raw materials for our current and upcoming products, domestically and internationally,” said Green Cures CEO Robert Calkin.

Green Cures is scheduled to be part of the “International Cannabis Association” exposition scheduled for June 22, 2014, in Las Vegas, Nevada, where they will proudly showcase their current and upcoming line of products and services available to the public.

Read Full Press Release: online.wsj